Agency Information Collection Activities; Announcement of OMB Approval; Salmonella Discovery System Pilot Study

---
identifier: "/us/fr/02-26619"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agency Information Collection Activities; Announcement of OMB Approval; Salmonella Discovery System Pilot Study"
title_number: 0
title_name: "Federal Register"
section_number: "02-26619"
section_name: "Agency Information Collection Activities; Announcement of OMB Approval; Salmonella Discovery System Pilot Study"
positive_law: false
currency: "2002-10-18"
last_updated: "2002-10-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "02-26619"
document_type: "notice"
publication_date: "2002-10-18"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "67 FR 64389"
fr_volume: 67
docket_ids:
  - "Docket No. 01N-0590"
fr_action: "Notice."
---


#  Agency Information Collection Activities; Announcement of OMB Approval; Salmonella Discovery System Pilot Study

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is announcing that a collection of information entitled “Salmonella Discovery System Pilot Study” has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995 (the PRA).

**FOR FURTHER INFORMATION CONTACT:**

Karen L. Nelson, Office of Information Resources Management (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1482.

**SUPPLEMENTARY INFORMATION:**

In the *Federal Register* of January 28, 2002 (67 FR 3902), the agency announced that the proposed information had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB Control Number 0910-0493. The approval expires on September 30, 2005. A copy of the supporting statement for this information collection is available on the Internet at http://www.fda.gov/ohrms/dockets.

Dated: October 11, 2002.

Margaret M. Dotzel,

Associate Commissioner for Policy.